Syntr Health Technologies, LLC

Publicly observed

Irvine, United States

Seen in a public record (e.g. a government grant database); not otherwise verified.

Details and provenance

Item	Value	Source	Status
Country	US	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed
City / locality	Irvine	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed
Name	Syntr Health Technologies, LLC	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed
UEI (U.S. federal entity ID)	DTC9T712PUB3	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed

Grant22 Sept 2026Publicly observed
NIH SBIR/STTR award: Prevention of Amputation with Rapid Healing of Diabetic Ulcers Using Autologous Microsized Fat Tissue
USD 313,372.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
Grant25 Sept 2025Publicly observed
NIH SBIR/STTR award: Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue Microsizing
USD 1,000,251.00 · National Center for Advancing Translational Sciences · Source: NIH RePORTER (opens in a new tab)
Grant25 Sept 2025Publicly observed
NIH SBIR/STTR award: Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue Microsizing
USD 1,050,276.00 · National Center for Advancing Translational Sciences · Source: NIH RePORTER (opens in a new tab)
Grant2 Sept 2025Publicly observed
NIH SBIR/STTR award: Accelerating Bioengineering Approaches for Increasing Access to New Solutions Targeting Breast Cancer Reconstructive Surgery
USD 356,500.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
Grant15 Aug 2025Publicly observed
NIH SBIR/STTR award: Rapid and Automated Dissociation of Tumor Tissue for Single Cell Diagnostics
USD 406,500.00 · National Center for Advancing Translational Sciences · Source: NIH RePORTER (opens in a new tab)

Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.